Clinical impact of epithelial–mesenchymal transition for cancer therapy

Nobendu Mukerjee(Gopalganj Science and Technology University), Nanasaheb D. Thorat(University of Limerick)
Clinical and Translational Discovery
January 28, 2024
10.1002/ctd2.260
Cited by 19

Related Papers

Plant-derived selenium nanoparticles: investigating unique morphologies, enhancing therapeutic uses, and leading the way in tailored medical treatments
|Materials Advances|2024|56
Antimalarial drug discovery against malaria parasites through haplopine modification: An advanced computational approach
|Journal of Cellular and Molecular Medicine|2023|50
A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives
|PLoS ONE|2023|48
Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: an in silico strategy leveraging molecular docking and dynamics simulation
|Frontiers in Microbiology|2023|38
Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach
|Frontiers in Oncology|2023|37